Medinotec (MDNC) Change in Account Payables (2022 - 2026)
Medinotec (MDNC) posted Change in Account Payables of $88702.0 for Q2 2026, up 142.9% on a QoQ basis from -$206765.0 in Q1 2026, and down 87.31% year-over-year from $699024.0 in Q2 2025.
Medinotec (MDNC) Change in Account Payables (2022 - 2026) Analysis & Trends
Medinotec's Change in Account Payables history runs 5 years deep, the most recent figure standing at $88702.0 for Q2 2026.
- Quarterly Change in Account Payables fell 87.31% year-over-year to $88702.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was -$954856.0 (down 206.52% YoY) and the FY2026 annual result came in at -$344534.0, down 251.87% from the prior year.
- Change in Account Payables was $88702.0 for Q2 2026 at Medinotec, up from -$206765.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $699024.0 in Q2 2025 and bottomed at -$800621.0 in Q3 2025.
- A 5-year average of $30166.5 and a median of -$5370.5 in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2024 — Change in Account Payables jumped 2513.83% — and 2026, when it tumbled 252.92%.
- Medinotec's Change in Account Payables stood at -$21206.0 in 2022, then surged by 1402.07% to $276118.0 in 2023, then plunged by 203.83% to -$286705.0 in 2024, then jumped by 87.38% to -$36172.0 in 2025, then surged by 345.22% to $88702.0 in 2026.
- Business Quant data shows MDNC's Change in Account Payables at $88702.0 in Q2 2026, -$206765.0 in Q1 2026, and -$36172.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 88,702.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 88,702.00 |
| May 31, 2026 | 88,702.00 |
| Feb 28, 2026 | -206,765.00 |
| Feb 28, 2026 | -206,765.00 |
| Nov 30, 2025 | -36,172.00 |
| Nov 30, 2025 | -36,172.00 |
| Aug 31, 2025 | -800,621.00 |
| Aug 31, 2025 | -800,621.00 |
| May 31, 2025 | 699,024.00 |
| May 31, 2025 | 699,024.00 |
| Feb 28, 2025 | -58,587.00 |
| Feb 28, 2025 | -58,587.00 |
| Nov 30, 2024 | -286,705.00 |
| Nov 30, 2024 | -286,705.00 |
| Aug 31, 2024 | 542,678.00 |
| Aug 31, 2024 | 542,678.00 |
| May 31, 2024 | 29,469.00 |
| May 31, 2024 | 29,469.00 |
| Feb 29, 2024 | 358,359.00 |
| Feb 29, 2024 | 358,359.00 |